Spinal Cord Stimulation Market by Component (Implantable Pulse Generator Devices, Leads), Indication (Failed Back Surgery Syndrome, Complex Regional Pain Syndrome, Ischemic Pain), End-User (Hospitals, Ambulatory Surgery Centers, Clinics) & Region for 2024-2031Spinal Cord Stimulation Market by Component (Implantable Pulse Generator Devices, Leads), Indication (Failed Back Surgery Syndrome, Complex

Published Date: August - 2024 | Publisher: MIR | No of Pages: 320 | Industry: latest updates trending Report | Format: Report available in PDF / Excel Format

View Details Download Sample Ask for Discount Request Customization

Spinal Cord Stimulation Market by Component (Implantable Pulse Generator Devices, Leads), Indication (Failed Back Surgery Syndrome, Complex Regional Pain Syndrome, Ischemic Pain), End-User (Hospitals, Ambulatory Surgery Centers, Clinics) & Region for 2024-2031Spinal Cord Stimulation Market by Component (Implantable Pulse Generator Devices, Leads), Indication (Failed Back Surgery Syndrome, Complex

Spinal Cord Stimulation Market Valuation – 2024-2031

The increasing prevalence of chronic pain and advancements in neuromodulation therapy are driving the growth of the spinal cord stimulation market. Businesses are integrating advanced spinal cord stimulation devices into their treatment offerings to address unmet medical needs, projecting the market to grow from an estimated USD 2.73 Billion in 2023 to USD 5.05 Billion by 2031.

Additionally, regulatory approvals and the expansion of indications covered by insurance for spinal cord stimulation are propelling market expansion at a CAGR of about 7.8% from 2024 to 2031.

Spinal Cord Stimulation MarketDefinition/Overview

Spinal cord stimulation involves the use of implantable devices that deliver electrical pulses to the spinal cord to manage chronic pain. The primary aim of spinal cord stimulation is to modulate pain signals before they reach the brain, thereby reducing the sensation of pain. This treatment is typically considered when other pain management therapies have failed, are unsuitable or are too invasive.

Spinal Cord Stimulation (SCS) is a technique that employs electrical impulses to relieve chronic pain by interfering with pain signals before they reach the brain. It is commonly is utilized for treating illnesses such as failed back surgery syndrome or neuropathy.

Spinal Cord Stimulation (SCS) is able to be used for enhanced pain treatment, increasing movement for paralysis patients, treating neurological illnesses, improving organ function and perhaps restoring lost sensory and motor functions.

What's inside a
industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Will Increasing Chronic Pain Cases Elevate the Demand for Spinal Cord Stimulation?

The spinal cord stimulation (SCS) market is witnessing significant growth, primarily driven by the increasing prevalence of chronic pain conditions. Conditions such as Failed Back Surgery Syndrome (FBSS) and Complex Regional Pain Syndrome (CRPS) are leading causes of chronic pain, affecting millions of people globally. FBSS, which occurs when a patient continues to experience pain after spinal surgery and CRPS, a chronic pain condition affecting a limb, both present substantial challenges in pain management. SCS is emerged as an effective treatment for these conditions, providing relief where other treatments have failed.

Additionally, the aging global population is contributing to the growth of the SCS market. As people age, they are more likely to suffer from chronic conditions that cause persistent pain. The increasing number of elderly individuals worldwide is led to a higher demand for advanced pain management solutions. Minimally invasive treatments like SCS are particularly appealing to this demographic, as they often involve shorter recovery times and lower risk compared to more invasive surgical options.

Technological advancements in SCS devices are also driving market growth. Innovations such as rechargeable and high-frequency devices have improved the efficacy and safety of these systems, making them more attractive to both patients and healthcare providers. Moreover, the integration of digital health technologies with SCS systems allows for remote monitoring and personalized pain management, further enhancing patient outcomes. As awareness of the benefits of SCS increases and healthcare infrastructure improves, especially in emerging markets, the demand for SCS devices is expecting to rise. Governments and healthcare organizations are also increasingly recognizing the importance of effective pain management in improving quality of life, leading to more supportive policies and increasing funding for pain management solutions. Consequently, the spinal cord stimulation market is poised for robust growth in the coming years.

Will Reimbursement Limitations Restrict the Adoption of Spinal Cord Stimulation Devices?

Reimbursement constraints are a significant barrier to the widespread adoption of spinal cord stimulation (SCS) devices. In many healthcare markets, including the United States and parts of Europe, the extent to which these devices are covered by insurance directly affects their accessibility to patients. Without comprehensive coverage, the high cost of SCS devices and the associated surgical procedures can be prohibitive for many patients, limiting market growth. Insurance providers often require extensive evidence of efficacy and cost-effectiveness before granting approval for reimbursement. This requirement can delay the adoption of newer, potentially more effective spinal cord stimulation technologies that lack long-term data. Additionally, variations in coverage policies between different insurers and across regions can create inconsistencies in patient access, making it challenging for manufacturers to predict market potential and plan strategic expansions.

To overcome these hurdles, manufacturers need to engage in extensive clinical trials that not only prove the clinical benefits but also demonstrate the long-term cost savings associated with the use of their devices, such as reduced reliance on pain medications and decreased overall healthcare utilization. Strengthening the case for SCS devices through solid health economic outcomes could persuade insurance companies to offer better reimbursement rates, thereby enhancing patient access and supporting market growth.

Category-Wise Acumens

Will Advancements in Implantable Pulse Generator Devices Propel Market Growth?

Advancements in implantable pulse generator (IPG) devices are poised to significantly propel the Spinal Cord Stimulation (SCS) market forward. These devices, which are a critical component of SCS systems, have seen substantial technological innovations that enhance their appeal and functionality. Key improvements include the reduction in device size, which allows for less invasive implantation procedures and Increasing patient comfort. Smaller IPGs are easier to implant and cause less tissue damage, making the procedure more acceptable to a broader range of patients. Enhanced battery life is another major development in IPG technology. Longer battery life reduces the need for frequent replacements, which not only lowers the overall treatment cost but also minimizes the need for additional surgical interventions. This improvement is particularly beneficial for patients requiring long-term pain management, as it ensures a more continuous and uninterrupted therapy.

Additionally, remote programming and monitoring capabilities allow physicians to make adjustments to the therapy without requiring the patient to visit the clinic frequently, thereby improving patient convenience and compliance. These technological enhancements in IPG devices are expecting to drive the adoption of SCS systems by making them more user-friendly and effective in managing chronic pain conditions. Physicians are more likely to recommend these advanced devices due to their improved performance and ease of use, while patients benefit from the increase comfort and reduced need for frequent surgical interventions. As a result, the SCS market is anticipated to witness significant growth, driven by the continuous advancements in IPG technology and the ongoing efforts to improve patient outcomes in chronic pain management. Leads are a crucial component of Spinal Cord Stimulation systems, responsible for delivering electrical impulses from the implantable pulse generator to the spinal cord. Advances in lead technology, including improve flexibility and durability, enhance the precision and reliability of pain management, making SCS more effective and patient-friendly.

Will Increasing Use in Ambulatory Surgery Centers Enhance Accessibility to Spinal Cord Stimulation?

The increasing use of spinal cord stimulation (SCS) therapies in ambulatory surgery centers (ASCs) is poised to significantly enhance the accessibility and affordability of these treatments. ASCs offer a cost-effective alternative to traditional hospital settings by providing outpatient care that reduces the overall treatment costs. Patients benefit from quicker recovery times and a reduced risk of hospital-acquired infections, which are more prevalent in inpatient settings. This shift towards ASCs is expecting to make SCS therapies more accessible to a broader patient population suffering from chronic pain conditions. The convenience and efficiency of ASCs also lead to higher patient satisfaction and better health outcomes.

Furthermore, ASCs are equipped with advanced medical technologies and skilled healthcare professionals, ensuring high-quality care during the SCS implantation and follow-up processes. The increasing preference for minimally invasive procedures in ASCs aligns with the growing demand for less invasive pain management solutions. This trend is anticipated to drive the overall growth of the SCS market by expanding its reach and making it a viable option for more patients. As a result, the market is likely to see Increasing adoption of SCS therapies, further supported by favorable insurance coverage and reimbursement policies that recognize the cost-efficiency and effectiveness of ASCs. These questions delve into how specific components, broader indications for use, and emerging trends in care delivery settings are shaping the spinal cord stimulation market. They provide a comprehensive view that aligns with the initial market categorization, offering insights into the evolving landscape of SCS therapies and their impact on patient care and market growth. Hospitals and clinics are key end users in the Spinal Cord Stimulation market, providing comprehensive care for chronic pain management. Hospitals handle complex SCS implantation procedures and offer extensive post-operative care, while clinics focus on follow-up care and device management, ensuring continuous support and monitoring for patients.

Gain Access into Spinal Cord Stimulation Market Report Methodology

Country/Region Wise Acumens

Will Technological Innovation and Healthcare Reforms Enable North America to Dominate the Market?

In North America, particularly in the U.S., the adoption of spinal cord stimulation (SCS) is being driven by significant advancements in medical technology and supportive healthcare policies. The region benefits from a strong presence of major device manufacturers, which fosters innovation and ensures the availability of cutting-edge SCS systems. These companies are at the forefront of developing advanced devices with improved features such as miniaturization, enhanced battery life, and sophisticated programmability, making SCS therapies more effective and user-friendly. Supportive healthcare policies, including favorable reimbursement scenarios, play a crucial role in the market’s growth. These policies reduce the financial burden on patients and make advanced pain management solutions more accessible. The increasing prevalence of chronic pain conditions, such as Failed Back Surgery Syndrome (FBSS) and Complex Regional Pain Syndrome (CRPS), also contributes to the growing demand for SCS devices in the region. As the population ages, the incidence of these conditions rises, further driving the need for effective and minimally invasive pain management therapies.

Innovations in SCS technology, combined with a robust healthcare infrastructure and high healthcare spending, position North America as a leader in the global SCS market. The integration of SCS systems with digital health platforms for remote monitoring and personalized treatment is another emerging trend that enhances patient outcomes and supports market expansion. Overall, North America’s commitment to advancing medical technology and improving patient care ensures its continued dominance in the spinal cord stimulation market.

What Impact Will Be Increasing Healthcare Access Have on the Market in Asia Pacific?

Rapid healthcare infrastructure development and increasing access to chronic pain management solutions in Asia Pacific are expecting to drive significant growth in the spinal cord stimulation (SCS) market. Countries like China and India are at the forefront of this expansion, experiencing a surge in medical tourism as patients seek advanced pain management solutions. The influx of medical tourists is fueled by the availability of high-quality healthcare services at competitive costs, making these countries attractive destinations for patients from around the world. Improving healthcare policies in the region are also playing a crucial role in facilitating market growth. Governments are investing in healthcare infrastructure and implementing policies that support the adoption of advanced medical technologies, including SCS systems. These initiatives are aimed at enhancing the overall quality of healthcare and making cutting-edge treatments more accessible to the local population.

Increasing awareness about the benefits of spinal cord stimulation is another critical factor driving market penetration in Asia Pacific. Educational campaigns and outreach programs are helping to inform patients and healthcare providers about the effectiveness of SCS in managing chronic pain conditions such as Failed Back Surgery Syndrome (FBSS) and Complex Regional Pain Syndrome (CRPS). As a result, more patients are opting for SCS therapies, contributing to the market’s expansion. Furthermore, the growing prevalence of chronic pain conditions due to lifestyle changes and an aging population is driving the demand for effective pain management solutions. The combination of these factors is expecting to significantly boost the SCS market in Asia Pacific, positioning the region as a key growth driver in the global market.

Competitive Landscape

The competitive landscape of the spinal cord stimulation market features a blend of established medical device giants and innovative startups. These companies are distinguished by their developmental strategies, partnerships, and broad array of clinically approved devices tailored to diverse patient needs. Continuous product development and improvements in device functionality are essential for maintaining a competitive edge.

Key players in the market include

Medtronic PLC, Boston Scientific Corporation, Abbott Laboratories, Nevro Corp, Nuvectra, Stimwave Technologies, Synapse Biomedical.

Latest Developments

  • In January 2024, Boston Scientific launched a next-generation spinal cord stimulation system featuring novel waveform technology to address multiple pain areas simultaneously.
  • In March 2024, Abbott Laboratories received FDA approval for its new wireless spinal cord stimulator designed for full-body MRI compatibility, enhancing treatment accessibility for patients with complex pain needs.

Report Scope

REPORT ATTRIBUTESDETAILS
Study Period

2018-2031

Growth Rate

CAGR of ~7.8% from 2024 to 2031

Base Year for Valuation

2023

Historical Period

2018-2022

Forecast Period

2024-2031

Quantitative Units

Value in USD Billion

Report Coverage

Historical and Forecast Revenue Forecast, Historical and Forecast Volume, Growth Factors, Trends, Competitive Landscape, Key Players, Segmentation Analysis

Segments Covered
  • Component
  • Indication
  • End-User
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Key Players

Medtronic PLC, Boston Scientific Corporation, Abbott Laboratories, Nevro Corp, Nuvectra, Stimwave Technologies, Synapse Biomedical.

Customization

Report customization along with purchase available upon request

Spinal Cord Stimulation Market, By Category

Component

  • Implantable Pulse Generator DevicesIndustrial Access Control Market size was valued at USD 10.4 Billion in 2023 and is projected to reach USD 16.20 Billion by 2031, growing at a CAGR of 7.8% from 2024 to 2031.
  • Leads
  • Others

Indication

  • Failed Back Surgery Syndrome
  • Complex Regional Pain Syndrome
  • Ischemic Pain
  • Others

End-User

  • Hospitals
  • Ambulatory Surgery Centers
  • Clinics

Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.

Table of Content

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

List Tables Figures

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email